Global Single-Use Assemblies Market valued at $2.25 billion (2021), is set to witness a lucrative growth rate of 22% to reach $6.1 billion by 2026

A single-use assembly is a ready-to-use custom-made all-in-one solution made from different plastic components that are assembled into one whole, based on a customer-specific design.

Advantages of Single-use Assemblies bolsters its Market Demand

Bioprocessing end users usually undertake the in-house assembling of single-use systems. If connections between the various components are not made correctly, it might result in cross-contamination and leakage which in turn might lead to production delays. Ready-to-use single-use assemblies aptly address these issues.

Some of the major advantages that are driving its demand are:

  • Faster implementation of single-use assembly components in the bioprocess cycle
  • Fewer risks of cross-contamination and leakage 
  • Reduced labour, expense, and time for end-users resulting in cost reduction
  • Eliminates cleaning and downtime, among others

Favourable Funding for Manufacturing of Single-Use Solutions

In the past decade, single-use assemblies and technologies have witnessed wide adoption all across the world. Using single-use equipment decreases facility set-up expenses, lowers cleaning costs & cross-product/batch contamination risks, increases product integrity, reduces downtime, and improves facility flexibility and adaptability.

Favourable funding for the manufacturing of single-use solutions is expected to further drive the demand of the single-use assemblies market. For instance,

·    In January 2022, High Purity New England secured a USD 15M grant from the Biomedical Advanced Research and Development Authority (BARDA). The grant is expected to expand and accelerate the production of single-use assemblies, single-use pumps, single-use mixing systems, and sterile individually packaged components.

 “In bioprocessing, there are several advantages of single-use technology, but making it work requires access to the necessary tools—and lots of them.

A single-use assembly provides everything a bio processor requires: bags, tubing, connectors, and filters. It provides flexible, customized single-use solutions to accelerate pharmaceutical drug development and manufacturing. Ready-to-use assemblies allow the development and production of products in a wide range of sizes and for a variety of diseases. It is a critical component in the supply chain for the production of vaccines and medications around the world.” - Senior Director, Leading Single-use Assembly Manufacturer, United States

Competitive Landscape Analysis: Single-Use Assemblies Market

The global single-use assemblies market is marked by the presence of key market players such as Thermo Fisher Scientific, Inc., Sartorius Stedim Biotech, Danaher Corporation, Merck KGaA, Avantor, Inc., Saint-Gobain, and others.

Get Customized Report on Single-Use Assemblies Market @ https://meditechinsights.com/single-use-assemblies-market/

Comments

Post a Comment

Popular posts from this blog

Global Healthcare Companion Robots Market valued at about $3 billion (2020), is growing at a lucrative CAGR close to 20% through 2020-2025

Companion robots offer companionship and emotional support for the children, elderly, and disabled people. Over the years, the improvements in sensors, actuators, and AI have led to rise in interest in healthcare companion robots market. Rising aging population, the rising cost of elder care, and shortage of caregivers The population across the globe is aging and the number of caregivers in relation to the aging population is declining. In Japan, there will be an estimated shortage of 1 million caregivers by 2025. Moreover, the cost of elder care is also rising. Between 2019 and 2020, the cost of in-home care jumped by about 4.4%; assisted living costs surged by 6.2%; and nursing home costs increased by 3%. The use of robots instead could help reduce this cost. For instance, a monthly service contract for Stevie (a robot developed by Trinity College, Dublin) would likely run between 50-60% of the cost of hiring a human to do the same tasks, as per their claim. “The growing dispar...
Read more

Global Mycoplasma Testing Market is slated to see a lucrative growth rate of 11% by 2027

Mycoplasmas are the smallest known free-living microorganisms and are frequent contaminants of mammalian cell cultures. For the safety and purity of vaccines and other biological cell-derived products, it is crucial that the cell substrates and unprocessed bulk materials are free of adventitious agents, including mycoplasma.  In many cases, mycoplasmas vary from other forms of bacteria, making them difficult to culture and identify. Testing is done to detect mycoplasma like Mycoplasma hominis, Mycoplasma genitalium, Mycoplasma pneumoniae, and Ureaplasma urealyticum which can cause nongonococcal urethritis (NGU), prostate inflammation (prostatitis), vaginal discharge, and pelvic inflammatory disease (PID) in both men and women. Rising Concerns of Cell Culture Contamination to Trigger the Growth of the Global Mycoplasma Testing Market Mycoplasmas randomly contaminate the fluids used in the bioprocessing and cell culture. It is commonly known that primary cell cultures have a minimum...
Read more

Global Obesity Drugs Market valued at $2.3 billion in 2022, is expected to Witness a Healthy Growth of 25% by 2027

Obesity and overweight are defined as gain of additional fat thus leading to a number of diseases, which can be measured by using body mass index (BMI) as a baseline. A BMI of over 30 is generally considered as obese and a BMI of over 25 is considered as overweight. Obesity is a major risk factor to various diseases such as diabetes, heart diseases, and cancer; approximately over 650 million obese patients living across the world as as projected by World Health Organization (WHO). Rising Obese and Overweight Population to Trigger the Demand of Obesity Drugs Market Obesity is one of the topmost contributors to a number of medical diseases such as heart diseases, stroke, cancer and diabetes. World Obesity Atlas 2022 forecasted the growth of global obese population to be 16.1% in 2025, accounting for 892 million people which will further reach 1,025 million by 2030 with a healthy growth rate of 17.5% in 2030.  Some of the regional obesity burden estimated by World Obesity Atlas 202...
Read more